Amwell(AMWL) - 2025 Q4 - Annual Results

Exhibit 99.1 • Recorded Total Revenue of $55.3 million exceeding the previously provided financial guidance from Q3 o Achieved subscription revenue of $28.8 million o Recorded Amwell Medical Group ("AMG") visit revenue of $23.7 million • Reported gross margin of 51% • Net loss was ($25.2) million, compared to ($31.9) million in third quarter of 2025 • Adjusted EBITDA of ($10.3) million compared to ($12.7) million in the third quarter of 2025 • Total visits were 1.0 million; AMWELL® ANNOUNCES RESULTS FOR FOU ...